Zepbound Archives - Gilman Agency

By Marc Gilman (800) 927-9326 | marc@gilmanagency.com If you're one of the many Medicare beneficiaries who has looked into GLP-1…

Marc GilmanAugust 10, 2026

Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. The federal government on…

Marc GilmanJuly 5, 2026

A University of Michigan study comparing a comprehensive weight loss program including obesity experts against the usual care for high-risk…

Marc GilmanJuly 3, 2026

1: Not everyone with Medicare qualifies for GLP-1 coverage To be eligible for the Bridge program, you have to have…

Marc GilmanJuly 3, 2026

For decades, it’s been against the law for Medicare to pay for weight-loss medication. But that changed on July 1,…

Marc GilmanJuly 3, 2026

A new KFF analysis finds that 3.8 million Medicare beneficiaries met the criteria to be eligible for the new Medicare…

Marc GilmanJune 30, 2026

CMS is launching the Medicare GLP-1 Bridge demonstration July 1, 2026. The Bridge program will provide eligible Medicare beneficiaries with…

Marc GilmanJune 23, 2026

Millions of Medicare patients will be eligible for GLP-1 weight loss drugs under the Medicare GLP-1 Bridge — which rolls…

Marc GilmanJune 22, 2026

Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research as reported in the New…

Marc GilmanJune 20, 2026

Are you currently taking a GLP1 drug only for weight loss? In order to assist Medicare eligible individuals who are…

Marc GilmanJune 18, 2026